We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00041782
Recruitment Status : Terminated
First Posted : July 19, 2002
Last Update Posted : July 31, 2012
Brookdale University Hospital Medical Center
Josephine Ford Cancer Center
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : January 2005
  Study Completion Date : January 2005